« Back to Record
Citation APA

Solinas, C., Sotiriou, C., Willard-Gallo, K., Ignatiadis, M., Ceppi, M., Lambertini, M., Scartozzi, M., Buisseret, L., Garaud, S., Fumagalli, D., de Azambuja, E., & Salgado, R. (2017). Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials. Cancer treatment reviews, 57, 8-15. doi:10.1016/j.ctrv.2017.04.005


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/253181

Solinas, C., Sotiriou, C., Willard-Gallo, K., Ignatiadis, M., Ceppi, M., Lambertini, M., Scartozzi, M., Buisseret, L., Garaud, S., Fumagalli, D., de Azambuja, E., & Salgado, R. (2017). Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials. Cancer treatment reviews, 57, 8-15. doi:10.1016/j.ctrv.2017.04.005